FLIXABI®, Biogen’s Infliximab Biosimilar Referencing Remicade®, Approved in the European Union
Go back to FLIXABI®, Biogen’s Infliximab Biosimilar Referencing Remicade®, Approved in the European Union| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 227.07 -1.62 (0.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $228.69 | 52 Week High | $333.65 | |||
| Open | $227.02 | 52 Week Low | $223.02 | |||
| Day High | $229.41 | P/E | 29.07 | |||
| Day Low | $224.45 | EPS | $7.81 | |||
| Volume | 1,161,172 | |||||
